Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Tovinontrine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 383,570Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    After Disappointing Data, Imara Offloads It Sickle Cell Candidate, Shares Surge
    After Disappointing Data, Imara Offloads It Sickle Cell Candidate, Shares Surge

    08 Sep 2022

    // Vandana Singh YAHOO

    https://finance.yahoo.com/finance/news/disappointing-data-imara-offloads-sickle-130541406.html

    Vandana Singh YAHOO
    08 Sep 2022
    Share Share
    Imara flunks a pair of phase 2bs, wiping out clinical pipeline
    Imara flunks a pair of phase 2bs, wiping out clinical pipeline

    06 Apr 2022

    // F. Vinluan MEDCITY NEWS

    https://medcitynews.com/2022/04/imaras-two-trial-flops-in-blood-disorders-dim-drugs-prospects-in-heart-failure/

    F. Vinluan MEDCITY NEWS
    06 Apr 2022
    Share Share
    FDA Clears Imara's IND for Tovinontrine in HFpEF
    FDA Clears Imara's IND for Tovinontrine in HFpEF

    25 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/25/2372350/0/en/Imara-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-IND-for-Tovinontrine-IMR-687-for-Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF.html

    GLOBENEWSWIRE
    25 Jan 2022
    Share Share